| RS183894680 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
SPHEROCYTOSIS, TYPE 1 |
| RS1838970198 |
ABCA1
|
Health Risk |
Likely pathogenic |
— |
| RS183898615 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1838987290 |
ADAM22
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 61 |
| RS183899632 |
CPA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS183906248 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1839084095 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1839084305 |
COL5A1
|
Health Risk |
Pathogenic |
— |
| RS1839104595 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1839105353 |
PTCH1
|
Health Risk |
Pathogenic |
— |
| RS1839107392 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1839113498 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1839114207 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1839115028 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Neoplasm |
| RS183911558 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya angiopathy with developmental delay, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1839148591 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1839191116 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183920365 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS183921218 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS183921963 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Transitory neonatal diabetes mellitus |
| RS183923129 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1839233961 |
NEUROG3
|
Health Risk |
Pathogenic |
— |
| RS183923599 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS183924183 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Knobloch syndrome, Knobloch syndrome |
| RS1839245948 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1839255008 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1839273008 |
PTCH1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1839298779 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1839301103 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS183933829 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS183935795 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS183936286 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 3 |
| RS183939928 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS183939957 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1839400126 |
TCIRG1
|
Health Risk |
Pathogenic |
— |
| RS1839416809 |
ARFGEF1
|
Health Risk |
Pathogenic |
Delayed speech and language development, Global developmental delay |
| RS183942200 |
FLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Ichthyosis vulgaris, Dermatitis |
| RS1839422034 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1839470192 |
TG
|
Health Risk |
Pathogenic |
— |
| RS183949390 |
FMO3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS183950016 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS183950022 |
TXNRD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucocorticoid deficiency 5, Primary dilated cardiomyopathy |
| RS1839516520 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1839537297 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1839542247 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1839553121 |
MICU1
|
Health Risk |
Likely pathogenic |
— |
| RS1839558393 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1839622622 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1839625956 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS183967792 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1839681191 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS183968785 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 9, Meckel syndrome |
| RS183969516 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, MYO15A-related disorder |
| RS1839717773 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS183973249 |
TMEM70
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS183974372 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Nonsyndromic Congenital Heart Disease, Cardiovascular phenotype |
| RS1839745979 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1 |
| RS1839755896 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS1839765652 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1839803841 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1839804099 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS183981750 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial colorectal cancer, GALNT12-related disorder |
| RS1839888192 |
ARFGEF1
|
Health Risk |
Pathogenic |
Delayed speech and language development, Atypical behavior |
| RS183988980 |
SLC39A14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183991942 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS183994910 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS1839956628 |
DCLRE1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1839957089 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS1839959715 |
VCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1W, Dilated cardiomyopathy 1W |
| RS1839989630 |
ODAD2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS1839995781 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS1839996657 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS1840016313 |
ADAMTS13
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1840019690 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS1840027040 |
MICU1
|
Health Risk |
Pathogenic/Likely pathogenic |
Proximal myopathy with extrapyramidal signs, Proximal myopathy with extrapyramidal signs |
| RS1840040809 |
WAC
|
Health Risk |
Pathogenic |
WAC-related neurodevelopmental disorder, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS1840047074 |
CHST3
|
Health Risk |
Likely pathogenic |
— |
| RS1840050989 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS184006495 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS184006653 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Familial spontaneous pneumothorax |
| RS184006845 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1840069879 |
CHST3
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS1840077192 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1840094606 |
PTCH1
|
Health Risk |
Pathogenic |
Basal cell carcinoma, susceptibility to |
| RS1840098608 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1840101155 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1840109796 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell nevus syndrome 1 |
| RS1840113211 |
PTCH1
|
Health Risk |
Likely pathogenic |
Precocious puberty, Macrocephaly |
| RS1840114155 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS184018403 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS184018899 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS184021211 |
CYP4F22
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS184021903 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
SMARCB1-related schwannomatosis, Rhabdoid tumor predisposition syndrome 1 |
| RS1840249855 |
B4GALT1
|
Health Risk |
Pathogenic |
B4GALT1-congenital disorder of glycosylation, B4GALT1-congenital disorder of glycosylation |
| RS1840255421 |
HK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic anemia due to hexokinase deficiency, Hemolytic anemia due to hexokinase deficiency |
| RS184025552 |
MYL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy |
| RS184026653 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1F |
| RS1840277125 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell nevus syndrome 1 |
| RS1840281213 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1840282022 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Gorlin syndrome |